Tech Company Financing Transactions
Mission Bio Funding Round
On 7/12/2018, Mission Bio raised $28.4 million in investment from private investors.
Transaction Overview
Company Name
Announced On
7/12/2018
Transaction Type
Venture Equity
Amount
$28,420,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 32 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6000 Shoreline Ct. 104
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Mission Bio provides tools for the study of cellular heterogeneity in human health and life science research. Our approach relies on proprietary microfluidic droplet technology to deliver rapid and cost-effective solutions for molecular analysis of single cells.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Charlie Silver
Chief Financial Officer
Marcel Roche
Chief Technical Officer
Nigel Beard
Vice President
Anup Parikh
VP - Bus. Development
Darrin Crisitello
VP - Bus. Development
Harsha Kavuri
VP - Engineering
Adam Sciambi
VP - Human Resources
Sharon Hebrok
VP - Marketing
Hannah Viernes
VP - Product Management
Anjali Pradhan
VP - R & D
David Ruff
VP - Sales
George Kopitas
Browse more venture capital transactions:
Prev: 7/12/2018: UNYQ Design venture capital transaction
Next: 7/12/2018: Next Insurance venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs